These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8777575

  • 21. Placental 15-hydroxyprostaglandin dehydrogenase binding site requirements.
    Thaler-Dao H, Saintot M, Baudin G, Descomps B, Crastes de Paulet A.
    Adv Prostaglandin Thromboxane Res; 1976; 1():177-82. PubMed ID: 187036
    [No Abstract] [Full Text] [Related]

  • 22. Critical residues for the coenzyme specificity of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
    Cho H, Oliveira MA, Tai HH.
    Arch Biochem Biophys; 2003 Nov 15; 419(2):139-46. PubMed ID: 14592457
    [Abstract] [Full Text] [Related]

  • 23. NADP-dependent 15-hydroxyprostaglandin dehydrogenase is homologous to NAD-dependent 15-hydroxyprostaglandin dehydrogenase and other short-chain alcohol dehydrogenases.
    Wermuth B.
    Prostaglandins; 1992 Jul 15; 44(1):5-9. PubMed ID: 1641503
    [Abstract] [Full Text] [Related]

  • 24. Kinetic studies on 15-hydroxyprostaglandin dehydrogenase from human placenta.
    Schlegel W, Greep RO.
    Adv Prostaglandin Thromboxane Res; 1976 Jul 15; 1():159-62. PubMed ID: 187034
    [Abstract] [Full Text] [Related]

  • 25. Prostaglandin-metabolizing enzymes during pregnancy: characterization of NAD(+)-dependent prostaglandin dehydrogenase, carbonyl reductase, and cytochrome P450-dependent prostaglandin omega-hydroxylase.
    Okita RT, Okita JR.
    Crit Rev Biochem Mol Biol; 1996 Apr 15; 31(2):101-26. PubMed ID: 8740524
    [Abstract] [Full Text] [Related]

  • 26. High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships.
    Niesen FH, Schultz L, Jadhav A, Bhatia C, Guo K, Maloney DJ, Pilka ES, Wang M, Oppermann U, Heightman TD, Simeonov A.
    PLoS One; 2010 Nov 02; 5(11):e13719. PubMed ID: 21072165
    [Abstract] [Full Text] [Related]

  • 27. Cloning and expression of the cDNA for rat NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
    Zhang H, Matsuo M, Zhou H, Ensor CM, Tai HH.
    Gene; 1997 Mar 25; 188(1):41-4. PubMed ID: 9099857
    [Abstract] [Full Text] [Related]

  • 28. Studies on 15-hydroxyprostaglandin dehydrogenase with various prostaglandin analogues.
    Ohno H, Morikawa Y, Hirata F.
    J Biochem; 1978 Dec 25; 84(6):1485-94. PubMed ID: 216666
    [Abstract] [Full Text] [Related]

  • 29. The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone.
    Greenland KJ, Jantke I, Jenatschke S, Bracken KE, Vinson C, Gellersen B.
    Endocrinology; 2000 Feb 25; 141(2):581-97. PubMed ID: 10650939
    [Abstract] [Full Text] [Related]

  • 30. Expression of the cDNA for NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase as a catalytically active enzyme in Escherichia coli.
    Ensor CM, Tai HH.
    Prostaglandins Leukot Essent Fatty Acids; 1992 Jul 25; 46(3):219-22. PubMed ID: 1508955
    [Abstract] [Full Text] [Related]

  • 31. Local modulation by 11beta-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells.
    Patel FA, Sun K, Challis JR.
    J Clin Endocrinol Metab; 1999 Feb 25; 84(2):395-400. PubMed ID: 10022390
    [Abstract] [Full Text] [Related]

  • 32. Expression of NAD+ dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle.
    Michelet JF, Colombe L, Gautier B, Gaillard O, Benech F, Pereira R, Boulle C, Dalko-Csiba M, Rozot R, Neuwels M, Bernard BA.
    Exp Dermatol; 2008 Oct 25; 17(10):821-8. PubMed ID: 18328086
    [Abstract] [Full Text] [Related]

  • 33. Pulmonary and placental 15-hydroxyprostaglandin dehydrogenase in rat during pregnancy.
    Tsuruta K, Mori N.
    Eur J Obstet Gynecol Reprod Biol; 1988 Jan 25; 27(1):71-9. PubMed ID: 3338612
    [Abstract] [Full Text] [Related]

  • 34. Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases.
    Jarabak J, Fried J.
    Prostaglandins; 1979 Aug 25; 18(2):241-6. PubMed ID: 42948
    [Abstract] [Full Text] [Related]

  • 35. Purification of an NAD+-dependent 15-hydroxyprostaglandin dehydrogenase from the human placenta.
    Nagai K, Tsuruta K, Mori N.
    Prostaglandins Leukot Med; 1987 Feb 25; 26(2):123-32. PubMed ID: 3470813
    [Abstract] [Full Text] [Related]

  • 36. ROS-Mediated 15-Hydroxyprostaglandin Dehydrogenase Degradation via Cysteine Oxidation Promotes NAD+-Mediated Epithelial-Mesenchymal Transition.
    Wang W, Hu Y, Wang X, Wang Q, Deng H.
    Cell Chem Biol; 2018 Mar 15; 25(3):255-261.e4. PubMed ID: 29307841
    [Abstract] [Full Text] [Related]

  • 37. Endogenous inhibitor of 15-hydroxyprostaglandin dehydrogenase in human placenta.
    Nagai K, Mibe M, Mori N.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Dec 15; 38(3):157-61. PubMed ID: 2622970
    [Abstract] [Full Text] [Related]

  • 38. The primary prostaglandin-inactivating enzyme of human placenta is a dimeric short-chain dehydrogenase.
    Mak OT, Jörnvall H, Jeffery J.
    Biosci Rep; 1982 Jul 15; 2(7):503-8. PubMed ID: 7115903
    [Abstract] [Full Text] [Related]

  • 39. [NAD+-dependent 15-hydroxyprostaglandin dehydrogenase from the human term placenta].
    Tanaka T, Kotani T, Ohtaki S, Nagai K, Tsuruta K, Mori N.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr 15; 39(4):579-85. PubMed ID: 3585104
    [Abstract] [Full Text] [Related]

  • 40. Steroid regulation of prostaglandin dehydrogenase activity and expression in human term placenta and chorio-decidua in relation to labor.
    Patel FA, Clifton VL, Chwalisz K, Challis JR.
    J Clin Endocrinol Metab; 1999 Jan 15; 84(1):291-9. PubMed ID: 9920098
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.